Schedel I, Peest D, Stünkel K, Fricke M, Eckert G, Deicher H
Scand J Immunol. 1980;11(4):437-44. doi: 10.1111/j.1365-3083.1980.tb00010.x.
Antisera raised against idiotypic determinants (ID) of myeloma proteins and macroglobulins have been used to differentiate peripheral blood lymphocyte (PBL) populations from individual patients. ID-positive lymphocytes not resembling plasma cells have been regularly found in peripheral blood in these diseases. For further characterization ID-positive lymphocytes were enriched from the peripheral blood by affinity chromatography using heterologous anti-idiotypic sera. Two patients with IgG myeloma, one patient with Waldenström's macroglobulinaemia and two persons with benign monoclonal hyperglobulinaemia (BMH) were examined by this technique. The ID-positive PBL population was shown to be heterogeneous with respect to non-tumour-specific surface markers, such as sheep erythrocytes (SRBC), Fc and C receptors. Tumour-specific idiotypic determinants will thus allow a more correct recognition of the total tumour cell compartment in these diseases.
针对骨髓瘤蛋白和巨球蛋白独特型决定簇(ID)产生的抗血清已被用于区分个体患者外周血淋巴细胞(PBL)群体。在这些疾病的外周血中经常发现与浆细胞不同的ID阳性淋巴细胞。为了进一步表征,使用异源抗独特型血清通过亲和层析从外周血中富集ID阳性淋巴细胞。通过该技术检查了两名IgG骨髓瘤患者、一名瓦尔登斯特伦巨球蛋白血症患者和两名良性单克隆球蛋白血症(BMH)患者。结果显示,ID阳性PBL群体在非肿瘤特异性表面标志物方面存在异质性,如绵羊红细胞(SRBC)、Fc和C受体。因此,肿瘤特异性独特型决定簇将有助于更准确地识别这些疾病中的肿瘤细胞总体情况。